Stay updated on Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.

Latest updates to the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page
- Check2 days agoChange DetectedA banner announces changes to NIH websites and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during the transition.SummaryDifference1%

- Check9 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study details. This indicates an access restriction rather than a content update to the study information.SummaryDifference17%

- Check57 days agoChange DetectedA funding/identifier line for NIH grant/contract was added to the study's identifiers, and the site revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision metadata was updated from v3.6.4 to v3.6.5, indicating a newer version of the page content. This update represents a refreshed deployment of the page without changing the study details.SummaryDifference0.0%

Stay in the know with updates to Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.